McIntyre Gail Frances
Insider CIK 1492646 · FURX Senior Vice President-Research · ARAV Chief Scientific Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARAV Aravive, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 700,000 | — | $0 | 700,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 27,176 | — | $0 | 27,176 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 27,177 | — | $0 | 27,177 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2022-10-24 | 2022-10-26 | 54,353 | $0.92 | $50.0K | 65,490 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2022-01-24 | 2022-01-25 | 425,000 | — | $0 | 425,000 | SEC↗ |
| ARAV Aravive, Inc. | P Buy | 2021-06-29 | 2021-06-29 | 1,000 | $5.35 | $5.3K | 11,137 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2021-01-25 | 2021-01-26 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ARAV Aravive, Inc. | P Buy | 2020-12-04 | 2020-12-07 | 8,000 | $5.77 | $46.2K | 10,137 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-04-08 | 2020-04-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2020-01-22 | 2020-01-24 | 48,583 | — | $0 | 48,583 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 53,000 | — | $0 | 53,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 26,219 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 10,368 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 22,763 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 24,318 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-06-17 | 2014-06-18 | 8,008 | — | $0 | 26,219 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-06-17 | 2014-06-18 | 8,008 | $13.16 | $105.4K | 32,326 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-17 | 2014-06-18 | 8,008 | $105.00 | $840.8K | 24,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-06-16 | 2014-06-18 | 32,928 | — | $0 | 22,763 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-06-16 | 2014-06-18 | 3,717 | — | $0 | 34,227 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-06-16 | 2014-06-18 | 26,000 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-06-16 | 2014-06-18 | 3,717 | $13.16 | $48.9K | 28,035 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-16 | 2014-06-18 | 3,717 | $105.05 | $390.5K | 24,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-16 | 2014-06-18 | 26,000 | $105.01 | $2.73M | 24,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-06-16 | 2014-06-18 | 26,000 | $15.00 | $390.0K | 50,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-16 | 2014-06-18 | 32,928 | $105.00 | $3.46M | 24,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-06-16 | 2014-06-18 | 32,928 | $9.11 | $300.0K | 57,246 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-16 | 2014-06-18 | 3,804 | $105.00 | $399.4K | 24,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-06-10 | 2014-06-12 | 1,746 | $104.58 | $182.6K | 28,122 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2014-02-28 | 2014-03-04 | 12,000 | — | $0 | 29,868 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2013-07-19 | 2013-07-23 | 20,000 | — | $0 | 55,691 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | F Tax w/h | 2013-07-19 | 2013-07-23 | 9,419 | $40.00 | $376.8K | 28,449 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-07-19 | 2013-07-23 | 10,581 | $40.00 | $423.2K | 17,868 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2013-07-19 | 2013-07-23 | 20,000 | $9.11 | $182.2K | 37,868 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-07-19 | 2013-09-18 | 20,000 | $40.00 | $800.0K | 17,868 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2013-06-10 | 2013-06-12 | 11,100 | — | $0 | 17,868 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award deriv | 2012-02-24 | 2012-04-11 | 10,368 | — | $0 | 10,368 | SEC↗ |